Pan-TRK Immunohistochemistry: A useful diagnostic adjunct for secretory carcinoma of the breast

Beth T. Harrison, Elizabeth Fowler, Gregor Krings, Yunn Yi Chen, Gregory R. Bean, Anne Vincent-Salomon, Laetitia Fuhrmann, Sandra E. Barnick, Beiyun Chen, Elizabeth M. Hosfield, Jason L. Hornick, Stuart J. Schnitt

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Secretory carcinoma is a special-type breast carcinoma underpinned by a recurrent t(12;15)(p13;q25) translocation resulting in ETV6-NTRK3 gene fusion. Immunohistochemistry (IHC) using a pan-TRK antibody has been recently shown to help identify NTRK rearrangements in other tumor types. The purpose of this study was to assess the diagnostic utility of pan-TRK IHC in secretory carcinoma of the breast. Pan-TRK IHC was performed using a rabbit monoclonal antibody on whole sections of 24 breast secretory carcinomas and tissue microarray sections of other breast carcinoma types (n=203) and histologic mimics (n=15). Cases were assessed for staining intensity and localization. The 24 patients with secretory carcinoma had a median age of 44 years and a median tumor size of 1.0 cm. ETV6 fluorescence in situ hybridization was positive in all cases tested (n=20). Twenty-three cases (95.8%) showed staining with pan-TRK, which was exclusively nuclear in 19, primarily nuclear with weak cytoplasmic staining in 3, and primarily cytoplasmic with focal nuclear staining in 1. The nuclear staining was diffuse in 17 and at least focally strong in 17. The only pan-TRK negative case was a core biopsy with limited tumor. Among the 203 nonsecretory carcinomas, 21 (10.3%) showed focal, weak nuclear staining in <5% of tumor cells and 1 (0.5%) showed focal membranous staining. All histologic mimics were negative. In conclusion, diffuse and/or at least focally strong nuclear pan-TRK staining is a sensitive and specific marker for secretory carcinoma of the breast.

Original languageEnglish (US)
JournalAmerican Journal of Surgical Pathology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Immunohistochemistry
Staining and Labeling
Carcinoma
Neoplasms
Breast Neoplasms
Secretory breast carcinoma
Gene Fusion
Fluorescence In Situ Hybridization
Monoclonal Antibodies
Rabbits
Biopsy
Antibodies

Keywords

  • NTRK rearrangements
  • pan-TRK
  • secretory carcinoma

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

Harrison, B. T., Fowler, E., Krings, G., Chen, Y. Y., Bean, G. R., Vincent-Salomon, A., ... Schnitt, S. J. (Accepted/In press). Pan-TRK Immunohistochemistry: A useful diagnostic adjunct for secretory carcinoma of the breast. American Journal of Surgical Pathology. https://doi.org/10.1097/PAS.0000000000001366

Pan-TRK Immunohistochemistry : A useful diagnostic adjunct for secretory carcinoma of the breast. / Harrison, Beth T.; Fowler, Elizabeth; Krings, Gregor; Chen, Yunn Yi; Bean, Gregory R.; Vincent-Salomon, Anne; Fuhrmann, Laetitia; Barnick, Sandra E.; Chen, Beiyun; Hosfield, Elizabeth M.; Hornick, Jason L.; Schnitt, Stuart J.

In: American Journal of Surgical Pathology, 01.01.2019.

Research output: Contribution to journalArticle

Harrison, BT, Fowler, E, Krings, G, Chen, YY, Bean, GR, Vincent-Salomon, A, Fuhrmann, L, Barnick, SE, Chen, B, Hosfield, EM, Hornick, JL & Schnitt, SJ 2019, 'Pan-TRK Immunohistochemistry: A useful diagnostic adjunct for secretory carcinoma of the breast', American Journal of Surgical Pathology. https://doi.org/10.1097/PAS.0000000000001366
Harrison, Beth T. ; Fowler, Elizabeth ; Krings, Gregor ; Chen, Yunn Yi ; Bean, Gregory R. ; Vincent-Salomon, Anne ; Fuhrmann, Laetitia ; Barnick, Sandra E. ; Chen, Beiyun ; Hosfield, Elizabeth M. ; Hornick, Jason L. ; Schnitt, Stuart J. / Pan-TRK Immunohistochemistry : A useful diagnostic adjunct for secretory carcinoma of the breast. In: American Journal of Surgical Pathology. 2019.
@article{5e01405305ad4205b3a8cab68a0f6e1e,
title = "Pan-TRK Immunohistochemistry: A useful diagnostic adjunct for secretory carcinoma of the breast",
abstract = "Secretory carcinoma is a special-type breast carcinoma underpinned by a recurrent t(12;15)(p13;q25) translocation resulting in ETV6-NTRK3 gene fusion. Immunohistochemistry (IHC) using a pan-TRK antibody has been recently shown to help identify NTRK rearrangements in other tumor types. The purpose of this study was to assess the diagnostic utility of pan-TRK IHC in secretory carcinoma of the breast. Pan-TRK IHC was performed using a rabbit monoclonal antibody on whole sections of 24 breast secretory carcinomas and tissue microarray sections of other breast carcinoma types (n=203) and histologic mimics (n=15). Cases were assessed for staining intensity and localization. The 24 patients with secretory carcinoma had a median age of 44 years and a median tumor size of 1.0 cm. ETV6 fluorescence in situ hybridization was positive in all cases tested (n=20). Twenty-three cases (95.8{\%}) showed staining with pan-TRK, which was exclusively nuclear in 19, primarily nuclear with weak cytoplasmic staining in 3, and primarily cytoplasmic with focal nuclear staining in 1. The nuclear staining was diffuse in 17 and at least focally strong in 17. The only pan-TRK negative case was a core biopsy with limited tumor. Among the 203 nonsecretory carcinomas, 21 (10.3{\%}) showed focal, weak nuclear staining in <5{\%} of tumor cells and 1 (0.5{\%}) showed focal membranous staining. All histologic mimics were negative. In conclusion, diffuse and/or at least focally strong nuclear pan-TRK staining is a sensitive and specific marker for secretory carcinoma of the breast.",
keywords = "NTRK rearrangements, pan-TRK, secretory carcinoma",
author = "Harrison, {Beth T.} and Elizabeth Fowler and Gregor Krings and Chen, {Yunn Yi} and Bean, {Gregory R.} and Anne Vincent-Salomon and Laetitia Fuhrmann and Barnick, {Sandra E.} and Beiyun Chen and Hosfield, {Elizabeth M.} and Hornick, {Jason L.} and Schnitt, {Stuart J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1097/PAS.0000000000001366",
language = "English (US)",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Pan-TRK Immunohistochemistry

T2 - A useful diagnostic adjunct for secretory carcinoma of the breast

AU - Harrison, Beth T.

AU - Fowler, Elizabeth

AU - Krings, Gregor

AU - Chen, Yunn Yi

AU - Bean, Gregory R.

AU - Vincent-Salomon, Anne

AU - Fuhrmann, Laetitia

AU - Barnick, Sandra E.

AU - Chen, Beiyun

AU - Hosfield, Elizabeth M.

AU - Hornick, Jason L.

AU - Schnitt, Stuart J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Secretory carcinoma is a special-type breast carcinoma underpinned by a recurrent t(12;15)(p13;q25) translocation resulting in ETV6-NTRK3 gene fusion. Immunohistochemistry (IHC) using a pan-TRK antibody has been recently shown to help identify NTRK rearrangements in other tumor types. The purpose of this study was to assess the diagnostic utility of pan-TRK IHC in secretory carcinoma of the breast. Pan-TRK IHC was performed using a rabbit monoclonal antibody on whole sections of 24 breast secretory carcinomas and tissue microarray sections of other breast carcinoma types (n=203) and histologic mimics (n=15). Cases were assessed for staining intensity and localization. The 24 patients with secretory carcinoma had a median age of 44 years and a median tumor size of 1.0 cm. ETV6 fluorescence in situ hybridization was positive in all cases tested (n=20). Twenty-three cases (95.8%) showed staining with pan-TRK, which was exclusively nuclear in 19, primarily nuclear with weak cytoplasmic staining in 3, and primarily cytoplasmic with focal nuclear staining in 1. The nuclear staining was diffuse in 17 and at least focally strong in 17. The only pan-TRK negative case was a core biopsy with limited tumor. Among the 203 nonsecretory carcinomas, 21 (10.3%) showed focal, weak nuclear staining in <5% of tumor cells and 1 (0.5%) showed focal membranous staining. All histologic mimics were negative. In conclusion, diffuse and/or at least focally strong nuclear pan-TRK staining is a sensitive and specific marker for secretory carcinoma of the breast.

AB - Secretory carcinoma is a special-type breast carcinoma underpinned by a recurrent t(12;15)(p13;q25) translocation resulting in ETV6-NTRK3 gene fusion. Immunohistochemistry (IHC) using a pan-TRK antibody has been recently shown to help identify NTRK rearrangements in other tumor types. The purpose of this study was to assess the diagnostic utility of pan-TRK IHC in secretory carcinoma of the breast. Pan-TRK IHC was performed using a rabbit monoclonal antibody on whole sections of 24 breast secretory carcinomas and tissue microarray sections of other breast carcinoma types (n=203) and histologic mimics (n=15). Cases were assessed for staining intensity and localization. The 24 patients with secretory carcinoma had a median age of 44 years and a median tumor size of 1.0 cm. ETV6 fluorescence in situ hybridization was positive in all cases tested (n=20). Twenty-three cases (95.8%) showed staining with pan-TRK, which was exclusively nuclear in 19, primarily nuclear with weak cytoplasmic staining in 3, and primarily cytoplasmic with focal nuclear staining in 1. The nuclear staining was diffuse in 17 and at least focally strong in 17. The only pan-TRK negative case was a core biopsy with limited tumor. Among the 203 nonsecretory carcinomas, 21 (10.3%) showed focal, weak nuclear staining in <5% of tumor cells and 1 (0.5%) showed focal membranous staining. All histologic mimics were negative. In conclusion, diffuse and/or at least focally strong nuclear pan-TRK staining is a sensitive and specific marker for secretory carcinoma of the breast.

KW - NTRK rearrangements

KW - pan-TRK

KW - secretory carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85072205206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072205206&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000001366

DO - 10.1097/PAS.0000000000001366

M3 - Article

AN - SCOPUS:85072205206

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

ER -